CARTITUDE-1 final results: phase 1b/2 study of ciltacabtagene autoleucel in heavily pretreated patients with relapsed/refractory multiple myeloma

被引：0

作者：

Jagannath, Sundar ^{[1
]}

Martin, Thomas ^{[2
]}

Usmani, Saad ^{[3
]}

Berdeja, Jesus ^{[4
]}

Jakubowiak, Andrzej ^{[5
]}

Agha, Mounzer ^{[6
]}

Cohen, Adam ^{[1
,7
]}

Deol, Abhinav ^{[8
]}

Htut, Myo ^{[9
]}

Lesokhin, Alexander ^{[3
]}

Munshi, Nikhil ^{[10
,11
]}

O'Donnell, Elizabeth ^{[12
]}

Jackson, Carolyn ^{[13
]}

Yeh, Tzu-Min ^{[13
]}

Banerjee, Arnob ^{[14
]}

Zudaire, Enrique ^{[14
]}

Madduri, Deepu ^{[13
]}

DelCorral, Christopher ^{[15
]}

Pacaud, Lida ^{[15
]}

Lin, Yi ^{[16
]}

机构：

[1] Mt Sinai Med Ctr, New York, NY USA

[2] Univ Calif San Francisco, San Francisco, CA USA

[3] Mem Sloan Kettering Canc Ctr, New York, NY USA

[4] Sarah Cannon Res Inst, Nashville, TN USA

[5] Univ Chicago, Chicago, IL USA

[6] UPMC Hillman Canc Ctr, Pittsburgh, PA USA

[7] Univ Penn, Perelman Sch Med, Abramson Canc Ctr, Philadelphia, PA USA

[8] Wayne State Univ, Karmanos Canc Inst, Detroit, MI USA

[9] City Hope Comprehens Canc Ctr, Duarte, CA USA

[10] Dana Farber Canc Inst, Boston, MA USA

[11] Harvard Med Sch, Vet Affairs Boston Healthcare Syst, Boston, MA 02115 USA

[12] Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA USA

[13] Janssen Res & Dev, Raritan, NJ USA

[14] Janssen Res & Dev, Spring House, PA USA

[15] Legend Biotech USA Inc, Somerset, NJ USA

[16] Mayo Clin, Rochester, MN USA

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P-275

引用

页码：S187 / S187

页数：1

共 50 条

[31] Phase 1b Results for Subcutaneous Talquetamab Plus Daratumumab in Patients with Relapsed/Refractory Multiple Myeloma
Chari, Ajai
Hari, Parameswaran
Bahlis, Nizar J.
Mateos, Maria-Victoria
van de Donk, Niels W. C. J.
Dholaria, Bhagirathbhai
Garfall, Alfred L.
Goldschmidt, Hartmut
Kortuem, K. Martin
Krishnan, Amrita Y.
Martin, Thomas
Morillo Gilles, Daniel
Oriol, Albert
Reece, Donna E.
Rodriguez, Cesar
Rodriguez-Otero, Paula
San-Miguel, Jesus F.
Usmani, Saad Z.
Verona, Raluca I.
Lin, Shun Xin Wang
Prior, Thomas J.
Wade, Mark
Weiss, Brendan M.
Goldberg, Jenna D.
Askari, Elham
BLOOD, 2021, 138
[32] Efficacy and safety of ciltacabtagene autoleucel in patients with relapsed/refractory multiple myeloma and prior noncellular anti-BCMA therapy: CARTITUDE-2 cohort C
Cohen, Adam
Cohen, Yael
Suvannasankha, Attaya
van de Donk, Niels
San-Miguel, Jesus
De Braganca, Kevin
Jackson, Carolyn
Schecter, Jordan
Vlummens, Philip
Varsos, Helen
Corsale, Christina
Mistry, Pankaj
Song, Qingxuan
Roccia, Tito
Geng, Dong
Zhu, Jieqing
Akram, Muhammad
Mateos, Maria-Victoria
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S167 - S168
[33] Comparison of outcomes with ciltacabtagene autoleucel (cilta-cel) in CARTITUDE-1 versus real-world standard of care (RW SOC) for patients (pts) with triple-class exposed relapsed/refractory multiple myeloma (RRMM).
Martin, Thomas G.
Krishnan, Amrita Y.
Yong, Kwee
Mehra, Katja Weisel Maneesha
Nair, Sandhya
Qi, Keqin
Londhe, Anil
Diels, Joris
Crivera, Concetta
Jackson, Carolyn Chang
Olyslager, Yunsi
Vogel, Martin
Schecter, Jordan Mark
Banerjee, Arnob
Valluri, Satish
Usmani, Saad Zafar
Berdeja, Jesus G.
Jagannath, Sundar
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[34] Comparative Efficacy of Ciltacabtagene Autoleucel in CARTITUDE-1 vs Physician’s Choice of Therapy in the Long-Term Follow-Up of POLLUX, CASTOR, and EQUULEUS Clinical Trials for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma
Katja Weisel
Thomas Martin
Amrita Krishnan
Sundar Jagannath
Anil Londhe
Sandhya Nair
Joris Diels
Martin Vogel
Jordan M. Schecter
Arnob Banerjee
Jesus G. Berdeja
Tonia Nesheiwat
Ashraf Garrett
Keqin Qi
Satish Valluri
Saad Z. Usmani
Kwee Yong
Clinical Drug Investigation, 2022, 42 : 29 - 41
[35] Results from CARTITUDE-1: A Phase 1b/2 Study of JNJ-4528, a CAR-T Cell Therapy Directed Against B-Cell Maturation Antigen (BCMA), in Patients with Relapsed and/or Refractory Multiple Myeloma (R/R MM)
Madduri, Deepu
Usmani, Saad Z.
Jagannath, Sundar
Singh, Indrajeet
Zudaire, Enrique
Yeh, Tzu-Min
Allred, Alicia J.
Banerjee, Arnob
Goldberg, Jenna D.
Schecter, Jordan M.
Zhuang, Sen
Infante, Jeffrey R.
Rizvi, Syed
Fan, Xiaohu
Jakubowiak, Andrzej
Berdeja, Jesus G.
BLOOD, 2019, 134
[36] Updated long-term follow-up results of a phase 1b/2 study (FUMANBA-1) in patients with relapsed/refractory multiple myeloma (RRMM) treated with equecabtagene autoleucel
Li, Chunrui
Wang, Di
Fang, Baijun
Huang, He
Li, Jianyong
Chen, Bing
Liu, Jing
Ren, Hanyun
Dong, Yujun
Hu, Kai
Liu, Peng
Zhang, Xi
Mi, Jian-Qing
Li, Zhenyu
Ding, Kaiyang
Cai, Song-Bai
Gui, Hong-Yu
Wang, Wen
Qiu, Lugui
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S196 - S197
[37] A PHASE 1B STUDY OF VENETOCLAX COMBINED WITH BORTEZOMIB AND DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA
Moreau, P.
Chanan-Khan, A.
Roberts, A. W.
Agarwal, A. B.
Facon, T.
Kumar, S.
Touzeau, C.
Cordero, J.
Ross, J.
Munasinghe, W.
Jia, J.
Salem, A. H.
Leverson, J.
Maciag, P.
Verdugo, M.
Harrison, S. J.
HAEMATOLOGICA, 2017, 102 : 169 - 169
[38] A Phase 1b Study of Oprozomib with Dexamethasone or Pomalidomide and Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma
Hari, Parameswaran
Schroeder, Mark A.
Berenson, James R.
Jakubowiak, Andrzej
Kaufman, Jonathan L.
Voorhees, Peter M.
Fujii, Hisaki
Yang, Zhao
Galimi, Francesco
Shain, Kenneth H.
BLOOD, 2018, 132
[39] A Phase 1b Study of Venetoclax Combined with Bortezomib and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma
Moreau, Philippe
Chanan-Khan, Asher
Roberts, Andrew W.
Agarwal, Amit B.
Facon, Thierry
Kumar, Shaji
Touzeau, Cyrille
Cordero, Jaclyn
Ross, Jeremy
Munasinghe, Wijith
Jia, Jia
Salem, Ahmed H.
Leverson, Joel
Maciag, Paulo
Verdugo, Maria
Harrison, Simon J.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (01): : E16 - E16
[40] Final Analysis of a Phase 1b Study of Daratumumab in Combination with Carfilzomib and Dexamethasone for Relapsed or Refractory Multiple Myeloma (RRMM)
Chari, Ajai
Lonial, Sagar
Martinez-Lopez, Joaquin
Mateos, Maria-Victoria
Blade, Joan
Benboubker, Lotfi
Oriol, Albert
Otero, Paula Rodriguez
Pineiro, Luis
Jakubowiak, Andrzej
Olyslager, Yunsi
Wang, Jianping
Nnane, Ivo
Ukropec, Jon
Shreeve, Martin
Qi, Ming
Moreau, Philippe
BLOOD, 2019, 134

← 1 2 3 4 5 →